載入...
Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance
Clinical antimicrobial susceptibility breakpoints are used to predict the clinical outcome of antimicrobial treatment. In contrast, microbiologic breakpoints are used to identify isolates that may be categorized as susceptible when applying clinical breakpoints but harbor resistance mechanisms that...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Centers for Disease Control and Prevention
2003
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3023429/ https://ncbi.nlm.nih.gov/pubmed/12890324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid0907.020589 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|